The legalization of cannabis products for medicinal and recreational purposes has raised the need for accurate and reliable analysis and testing methods to ensure their efficacy and regulatory compliance.
In this interview, AZoM and Sorbent Technologies speak to Hemp Synergistics' Vice President Jim Steiner about their collaboration to boost the quality of their cannabis products.
Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.
Research indicates a surge in cannabis use among older Michiganders, emphasizing health benefits, driving risks, and the importance of provider communication.
A study led by the UAB Institut de Neurociències and published in the journal Nature Communications demonstrates in animal models how daily administration of cannabidiol (CBD), a substance obtained from the cannabis plant, extends lifespan and improves symptoms associated with Leigh syndrome.
